Trazodone and triazolam: Acute subject-rated and performance-impairing effects in healthy volunteers

Psychopharmacology

Volumn 131, Issue 1, 1997, Pages 9-18

  Rush, Craig R ^a   Madakasira, Sudhakar ^a   Hayes, Catherine A ^a   Johnson, Camella A ^a   Goldman, Nancy H ^a   Pazzaglia, Peggy J ^a  

^a UNIVERSITY OF MISSISSIPPI SCHOOL OF MEDICINE   (United States)

Author keywords

Antidepressants; Benzodiazepines; Humans; Hypnotics; Learning; Memory; Performance; Recall; Trazodone; Triazolam

Indexed keywords

BENZODIAZEPINE DERIVATIVE; TRAZODONE; TRIAZOLAM;

ADULT; AMNESIA; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFECT; FEMALE; HUMAN; HUMAN EXPERIMENT; LEARNING DISORDER; MALE; NORMAL HUMAN; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; QUESTIONNAIRE; RECALL; SEDATION; TASK PERFORMANCE;

ADULT; DOSE-RESPONSE RELATIONSHIP, DRUG; DOUBLE-BLIND METHOD; FEMALE; HUMANS; LEARNING; MALE; MENTAL RECALL; TASK PERFORMANCE AND ANALYSIS; TIME FACTORS; TRAZODONE; TRIAZOLAM;

EID: 0031007728     PISSN: 00333158     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002130050259     Document Type: Article

References (62)

1. Amado-Boccara I, Gougoulis N, Littre MFP, Galinowski A, Loo H (1994) Effects of antidepressants on cognitive functions: a review. Neurosci Biobehav Rev 19:479-492
2. Bixler EO, Kales A, Soldatos C (1979) Prevalence of sleep disorders in the Los Angeles metropolitan area. Am J Psychiatry 136:1257-1262
3. Bliwise D, Seidel W, Karacan I, Mitler M, Roth T, Zorick F, Dement W (1983) Daytime sleepiness as a criterion in hypnotic medication trials: comparison of triazolam and flurazepam. Sleep 6:156-163
4. Brogden RN, Heel RC, Speight TM, Avery GS (1981) Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs 21:401-429
5. Bryant SG, Ereshefsky L (1982) Antidepressant properties of trazodone. Clin Pharm 1:406-417
6. Carskadon MA, Seidel WF, Greenglatt DJ, Dement WC (1982) Daytime carryover of triazolam and flurazepam in elderly insomniacs. Sleep 5:361-371
7. Cole S (1986) Effects of benzodiazepines on acquisitions and performance: a critical assessment. Neurosci Biobehav Rev 10: 265-272
8. Curran HV (1991) Benzodiazepines, memory, and mood: a review. Psychopharmacology 105:1-8
9. Curran HV, Sakulsriprong M, Lader M (1988) Antidepressants and human memory: an investigation of four drugs with different sedative and anticholinergic profiles. Psychopharmacology 95:520-527
10. Darke SG, Ross JE, Hall WD (1995) Benzodiazepine use among injecting heroin users. Med J Aust 162: 645-647
11. de Wit H, Gritffiths RR (1991) Testing the abuse liability of anxiolytic and hypnotic drugs in humans. Drug Alcohol Depend 28:83-111.
12. Dingemanse J (1995) Pharmacotherapy of insomnia: practice and prospects. Pharmacol World Sci 17: 67-75
13. Evans SM, Funderburk FR, Griffiths RR (1990) Zolpidem and triazolam in humans: behavioral and subjective effects and abuse liability. J Pharmacol Exp Ther 255:1246-1255
14. Georgotas A, Forsell TL, Mann JJ, Kim M, Gershon S (1982) Trazodone hydrochloride: a wide spectrum antidepressant with a unique pharmacological profile. A review of its neurochemical effects pharmacology, clinical efficacy, and toxicology. Pharmacotherapy 2:255-265
15. Ghoneim MM, Mewaldt SP (1990) Benzodiazepines and human memory: a review. Anesthesiology 72: 926-938
16. Gillin JC, Byerley WF (1990) The diagnosis and management of insomnia.N Engl J Med 322:239-248
17. Gorenstein C, Gentil V (1983) Residual and acute effects of flurazepam and triazolam in normal subjects. Psychopharmacology 80:376-379
18. Greenblatt DJ, Harmatz JS, Engelhardt N, Shader RI (1989) Pharmacokinetic determinants of dynamic differences among three benzodiazepine hypnotics. Arch Gen Psychiatry 46: 326-332
19. Griffiths RR, Bigelow GE, Liebson IA (1983) Differential effects of diazepam and pentobarbital on mood and behavior. Arch Gen Psychiatry 40:865-873
20. Haria M, Fitton A, McTavish D (1994) Trazodone: a review of its pharmacology, therapeutic use in depression and therapeutic potential in other disorders. Drugs Aging 4:331-355
21. Hartmann PM (1995) Drug treatment of insomnia: indications and newer agents. Am Family Physician 51: 191-194
22. Iguchi MY, Handelsman L, Bickel WK, Griffiths RR (1993) Benzodiazepine and sedative use/abuse by methadone maintenance clients. Drug Alcohol Depend 32:257-266
23. Jacobsen FM (1990) Low dose trazodone as a hypnotic in patients treated with MAOIs and other psychotropics: a pilot study. J Clin Psychiatry 51:298-302
24. Jasinski DR (1977) Assessment of the abuse potentiality of morphine-like drugs (methods used in man). In: Martin W (ed) Drug addiction I. Springer, New York, pp 197-258
25. Karacan I, Thornby JI, Anch M, Holzer CE, Warheit GJ, Schwab JJ, Williams RL (1976) Prevalence of sleep disturbance in a primarily urban Florida county. Soc Sci Med 10:239-244
26. Karniol IG, Dalton J, Lader M (1976) Comparative psychotropic effects of trazodone, imipramine and diazepam in normal subjects. Curr Ther Res 20:337-348
27. Liebowitz NR, El-Mallakh RS (1989) Trazodone for the treatment of anxiety symptoms in substance abusers. J Clin Psychopharmacol 9:449-451
28. Lister R (1985) The amnesic action of benzodiazepines in man. Neurosci Biobehav Rev 9:87-94
29. Lugaresci E, Zucconi M, Bixler EO (1987) Epidemiology of sleep disorders. Psychiatr Ann 17:446-453
30. Maczaj M (1993) Pharmacological treatment of insomnia. Drugs 45:44-55
31. Martin WR, Sloan JW, Sapiro JD, Jasinski DR (1971) Physiologic, subjective, and behavioral effects of amphetamine, methamphetamine, ephedrine, phenmetrazine, and methylphenidate in man. Clin Pharmacol Ther 12:245-258
32. McLeod DR, Griffiths RR, Bigelow GE, Yingling JE (1982) An automated version of the digit symbol substitution test (DSST). Behav Res Meth Instr 14:463-466
33. McNair DM, Lorr M, Droppleman LF (1971) Profile of mood states (manual). Educational and Industrial Testing Services, San Diego, Calif.
34. Miller N, Giannini A (1991) Drug misuse in alcoholics. Int J Addict 26:851-857
35. Monti JM, Monti D (1995) Pharmacological treatment of chronic insomnia. CNS Drugs 4:182-194
36. Mumford GK, Rush CR, Griffiths RR (1995a) Abecarnil and alprazolam in humans: behavioral, subjective and reinforcing effects. J Pharmacol Exp Ther 272:570-580
37. Mumford GK, Rush CR, Griffiths RR (1995b) A comparison of the abuse liability of alprazolam and DN-2327 (pazinaclone) in humans: psychomotor, memory, subjective and reinforcing effects. Exp Clin Psychopharmacol 3:39-48
38. Navaratnam V, Foong K (1990a) Adjunctive drug use among opiate addicts. Curr Med Res Opin 11:611-619
39. Navaratnam V, Foong K (1990b) Opiate dependence the role of benzodiazepines. Curr Med Res Opin 11:620-630
40. Ogura C, Nakazawa K, Majima K, Nakamura K, Ueda H, Umezawa Y, Wardell WM (1980) Residual effects of hypnotics: triazolam, flurazepam, and nitrazepam. Psychopharmacology 68:61-65
41. Olsen RW, Wong EHF, Stauber GB, King RG (1984) Biochemical pharmacology of the gamma-aminobutric acid receptor/ ionophore protein. Fed Proc 43:2772-2778
42. Rawls WN (1982) Trazodone. Drug Intell Clin Pharm 16:7-13
43. Roache JD, Griffiths RR (1985) Comparison of triazolam and pentobarbital: performance impairment, subjective effects and abuse liability. J Pharmacol Exp Ther 243:978-988
44. Roehrs T, Vogel G, Sterling W, Roth T (1990) Dose effects of temazepam in transient insomnia. Drug Res 40:859-862
45. Roth T, Roehrs TA, Stepanski EJ, Rosenthal LD (1990) Hypnotics and behavior. Am J Med 88 [suppl. 3A]:43S-46S
46. Rush CR, Griffiths RR (1996) Zolpidem, triazolam, and temazepam: behavioral and subject-rated effects in normal volunteers. J Clin Psychopharmacol 16:146-157
47. Rush CR, Higgins ST, Bickel WK, Hughes JR (1993a) Acute effects of trizolam and lorazepam on human learning, performance and subject ratings. J Pharmacol Exp Ther 264:1218-1226
48. Rush CR, Higgins ST, Bickel WK, Hughes JR (1993b) A comparison of the acute behavioral effects of triazolam and temazepam in normals. Psychopharmacology 112:407-414
49. Rush CR, Higgins ST, Bickel WK, Hughes JR (1994a) Acute behavioral effects of lorazepam and caffeine, alone and in combination, in humans. Behav Pharmacol 5:245-254
50. Rush CR, Higgins ST, Hughes JR, Bickel WK (1994b) Acute behavioral effects of triazolam and caffeine, alone and in combination, in humans. Exp Clin Psychopharmacol 2:211-222
51. Rush CR, Madakasira S, Goldman NH (1996) Acute behavioral effects of estazolam and triazolam in non-drug abusing volunteers. Exp Clin Psychopharmacol 4:300-307
52. Rush CR, Madakasira S, Goldman NH, Woolverton WL, Rowlett JK (1997) Discriminative-stimulus effects of zolpidem in pentobarbital-trained subjects: II. comparison with triazolam and caffeine in humans. J Pharmacol Exp Ther 290:174-188
53. Sakulsripong M, Curran HV, Lader M (1991) Does tolerance develop to the sedative and amnesic effects of antidepressants? Eur J Pharmacol 40:43-48
54. Synder SH, Enna SJ, Young AB (1977) Brain mechanisms associated with therapeutic actions of benzodiazepines: focus on neurotransmitters. Am J Psychiatry 134:662-665
55. Troisi JR II, Critchfield TS, Griffiths RR (1993) Buspirone and lorazepam abuse liability in humans: behavioral effects, subjective effects and choice. Behav Pharmacol 4:217-230
56. Volz HP, Sturm Y (1995) Antidepressant drugs and psychomotor performance. Neuropsychobiology 31 : 146-155
57. Walsh JK, Muehlbach MJ, Schweizer PK (1984) Acute administration of triazolam for daytime sleep of rotating shift workers. Sleep 7:223-229
58. Ware JC, Pittard JT (1990) Increased deep sleep after Irazodone use: a double-blind placebo-controlled study in healthy young adults. J Clin Psychiatry 51:18-22
59. Ware JC, Rose FV, McBrayer RH (1994) The acute effects of nefazodone, trazodone and buspirone on sleep and sleep-related penile tumescence in normal subjects. Sleep 17:544-550
60. Woods JH, Katz JL, Winger G (1987) Abuse liability of benzodiazepines. Annu Rev Pharmacol Toxicol 39:251-413
61. Woods JH, Katz JL, Winger G (1992) Benzodiazepines: use, abuse, and consequences. Pharmacol Rev 44:151-347
62. Wysowski DK, Baum C (1991) Outpatient use of prescription sedative-hypnotic drugs in the United States. 1970 through 1989. Arch Int Med 151:1779-1783